title: [Treatment of latent tuberculosis infection].
abstract: Latent tuberculosis infection is a key stage in the natural history of tuberculosis, and provides an important period where strategies to prevent the development of disease may be implemented. The treatment of latent tuberculosis infection is well described in many national guidelines. In this review, we attempt to help pneumonologists to implement these guidelines accurately and appropriately, prescribing preventive treatment when the benefit-risk ratio is optimal, providing treatment most safely, performing therapeutic education and incorporating preventive treatment into the full array of measures against tuberculosis.
authors.affiliation: Service de pneumologie, Nouvel hôpital civil, 1 place de l'Hôpital, Strasbourg cedex, France. philippe.fraisse@chru-strasbourg.fr
authors.forename: P
authors.initials: P
authors.lastname: Fraisse
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D017281:Cost of Illness; D004338:Drug Combinations; D006801:Humans; D015994:Incidence; D007538:Isoniazid / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D055985:Latent Tuberculosis / Q000191:economics / Q000453:epidemiology / Q000628:therapy* / Q000635:transmission; D012293:Rifampin / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics; D016896:Treatment Outcome; D016903:Drug Monitoring
chemical_list: D000995:Antitubercular Agents; D004338:Drug Combinations; D007538:Isoniazid; D012293:Rifampin